SEC Company Response from Vaxcyte, Inc. (PCVX) (CIK 0001649094) (PCVX) — Jun 9, 2020
Vaxcyte, Inc. (PCVX) (CIK 0001649094)
Date: June 9, 2020 · CIK: 0001649094 · Accession: 0001193125-20-164570
AI Filing Summary & Sentiment
File numbers found in text: 333-238630
Letter
VAXCYTE, INC.
353 Hatch Drive
Foster City, California 94404
June 9, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ada D. Sarmento
Mary Beth Breslin
Michael Fay
Al Pavot
RE: Vaxcyte, Inc.
Registration Statement on Form S-1
File No. 333-238630
Acceleration Request
Requested Date: Thursday, June 11, 2020
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Vaxcyte, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on Thursday, June 11, 2020, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant’s counsel may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Robert W. Phillips and J. Carlton Fleming of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Robert W. Phillips of Cooley LLP, counsel to the Registrant, at (415) 693-2020, or J. Carlton Fleming at (650) 843-5865.
[Signature Page Follows]
Very truly yours,
VAXCYTE, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VAXCYTE, INC. 353 Hatch Drive Foster City, California 94404 June 9, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ada D. Sarmento Mary Beth Breslin Michael Fay Al Pavot RE: Vaxcyte, Inc. Registration Statement on Form S-1 File No. 333-238630 Acceleration Request Requested Date: Thursday, June 11, 2020 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, Vaxcyte, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on Thursday, June 11, 2020, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant’s counsel may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Robert W. Phillips and J. Carlton Fleming of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Robert W. Phillips of Cooley LLP, counsel to the Registrant, at (415) 693-2020, or J. Carlton Fleming at (650) 843-5865. [Signature Page Follows] Very truly yours, VAXCYTE, INC. By: /s/ Jane Wright-Mitchell Name: Jane Wright-Mitchell Title: General Counsel cc: Grant E. Pickering, Vaxcyte, Inc. Robert W. Phillips, Cooley LLP Charles S. Kim, Cooley LLP J. Carlton Fleming, Cooley LLP Peter N. Handrinos, Latham & Watkins LLP Brian J. Cuneo, Latham & Watkins LLP Miles P. Jennings, Latham & Watkins LLP [Company Signature Page to Acceleration Request]